ArticleCancers2022

Plasma-Based microRNA Expression Analysis in Advanced Stage NSCLC Patients Treated with Nivolumab.

Alexia Monastirioti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.